CIMT vs. Calcium Score: The Heart Screening Test Your Doctor Might Not Be Telling You About

---

Most people think a zero calcium score means they're in the clear. Here's the uncomfortable truth: it doesn't always mean that.

A 52-year-old named Marcus came into our clinic recently. Zero calcium score. Clean scan. He was relieved—figured his heart was fine. But his CIMT test told a different story.

We found soft plaque building up in his carotid arteries. His coronary arteries hadn't calcified yet, but the writing was on the wall—literally. That's the thing about heart disease: the warning signs often show up years before the hard evidence does.

So which test actually catches those warning signs? Let's break it down.

---

Why Do Standard Heart Screenings Miss the Early Signs?

Traditional cardiovascular screening relies heavily on the Coronary Artery Calcium (CAC) score. Get a CT scan, check for calcium, done. If your score is zero, you're told you're low risk.

But here's what that approach misses:

• Soft plaque—the kind that's actively forming and most dangerous—doesn't show up on a calcium scan
• Younger patients often haven't developed calcified plaque yet, even when early disease is present
• A zero CAC score can give a false sense of security while atherosclerosis is silently progressing

The CAC score is great at one thing: confirming that calcified, advanced plaque exists. What it's not great at? Catching heart disease early, when you can actually do something about it.

That's where CIMT comes in.

---

How Does Each Test Work — What Does the Science Show?

CIMT: The Ultrasound That Sees Early

Carotid Intima-Media Thickness (CIMT) uses harmless sound waves—essentially an ultrasound of your neck—to measure how thick the inner layers of your carotid arteries have become.

What it measures: Both artery wall thickness AND the presence of plaque. Not just whether your arteries are getting thicker, but whether plaque is actually accumulating.

Why it matters: CIMT can detect soft plaque before it ever calcifies. That gives you years of advance warning that a CAC score would miss entirely.

The evidence backs this up. A Mayo Clinic study of 118 patients with cardiovascular risk factors found that 47% of patients with a zero CAC score still showed signs of atherosclerosis on CIMT (Lester SJ, et al. Mayo Clin Proc. 2009;84(3):229-33. PMID: 19252109). Nearly half of the "clean" CAC scans had hidden plaque lurking in the carotid arteries.

CAC Score: The CT Scan That Confirms Advanced Risk

The Coronary Artery Calcium (CAC) score uses a CT scan—with a small amount of radiation—to detect calcium deposits in your heart's arteries.

What it measures: Calcified, hardened plaque that's been around long enough to mineralize.

Why it matters: When calcium is present, it strongly predicts future cardiovascular events. Research from the Multi-Ethnic Study of Atherosclerosis (MESA) found that adding a carotid IMT score to Framingham risk factors and a positive CAC score further improved prediction of first-time coronary heart disease events over 10 years (Polak JF, et al. J Am Heart Assoc. 2017;6:e004612. PMID: 28110311). In other words, CIMT and CAC are more powerful together than either is alone.

The trade-off? CAC is best at confirming that advanced disease exists. It's less useful for catching it in its earliest, most treatable stages.

What Does the Head-to-Head Research Show?

The Heinz Nixdorf Recall study followed over 3,200 people for approximately 9 years and compared how well CIMT and CAC predicted strokes. Here's what they found (Gronewold J, et al. Stroke. 2014;45(9):2668-74. PMID: 25116876):

• CAC was the stronger predictor overall—each standard deviation increase in log(CAC+1) was associated with a 45% higher risk of stroke (HR 1.45)
• CIMT wasn't far behind—each standard deviation increase in CIMT was associated with a 34% higher risk (HR 1.34)
• The key finding: CAC, CIMT, and ankle-brachial index provide complementary information. Using them together captures more of the picture than any single test

The takeaway: these tests aren't competitors. CIMT catches early disease that CAC misses. CAC confirms advanced risk. Together, they give you the full story.

---

Patient Story: Marcus

Age: 52 | Risk factors: Family history of early heart disease, borderline hypertension, former smoker (quit 2 years ago) | Framingham Risk Score: Low (~6%)

Marcus came in for a comprehensive cardiovascular evaluation. His CAC score was zero—textbook normal. He was, in his own words, "pretty happy with those results."

But we also ran CIMT.

The ultrasound revealed plaque in both carotid arteries and an IMT at the 72nd percentile for his age and sex. His calculated "arterial age" came back at 62—a full decade older than his actual age.

The conversation went something like this:

"Marcus, your heart scan is clean. But your neck arteries are telling a different story. The plaque there hasn't calcified yet—so it doesn't show up on a CT scan. But it's there, and it matters."

We started him on a low-dose statin and intensified his lifestyle plan. Two years later, a repeat CIMT showed stable plaque with no progression. His arterial age had dropped from 62 to 58.

The takeaway: A zero CAC score gave Marcus a false sense of security. CIMT caught what the CT scan couldn't see—and gave him 5+ years of advance warning to change course.

---

When Should You Consider CIMT vs. CAC?

Consider CIMT if:

• You're under 55 with risk factors like family history, diabetes, or high blood pressure
• Your CAC score is zero but you still have concerns
• You want to track whether lifestyle changes or medication are actually working
• You prefer a test with zero radiation

Consider CAC if:

• You're over 55 and want to confirm whether calcified plaque is present
• You're weighing whether to start cholesterol medication
• Your traditional risk scores suggest intermediate risk and you need more clarity
• You're comfortable with a small amount of radiation (roughly equivalent to a mammogram)

Consider Both if:

• You want the most complete picture of your cardiovascular health
• Your CAC is zero but something still feels off
• You have a strong family history of early heart disease
• You want to monitor progression over time

---

What Is the Renew Approach to Comprehensive Risk Assessment?

At Renew, we believe in getting the full picture—not just the parts that are easy to see.

Our cardiovascular screening includes:

• CIMT with plaque quantification — We don't just measure thickness; we count and characterize actual plaque. Research from the ARIC study shows that carotid plaque presence is a stronger predictor of coronary heart disease than thickness measurements alone (Nambi V, et al. J Am Coll Cardiol. 2010;55(15):1600-7. PMID: 20378078).
• CAC score — For patients where it's appropriate, coronary CT confirms whether calcified plaque is present.
• Advanced lipid testing — Beyond standard cholesterol panels, we look at particle size, Lp(a), and other markers that routine care routinely misses.
• Metabolic panel — Blood sugar, insulin, and inflammation markers—because heart disease doesn't happen in isolation.

We use high-resolution ultrasound equipment specifically designed for CIMT, and our trained sonographers capture multiple carotid segments (common carotid, carotid bulb, internal carotid) for the most accurate assessment.

The goal: Give you information early enough to actually act on it.

---

What Interventions Actually Work When Tests Show Early Warning Signs?

If CIMT or CAC shows early warning signs, here's what the evidence supports:

Tier 1: Lifestyle Foundations

• Mediterranean-style diet — Shown to reduce cardiovascular events in primary prevention (PREDIMED trial)
• Regular aerobic exercise — Even moderate activity improves endothelial function and slows plaque progression
• Smoking cessation — Non-negotiable; every year after quitting measurably reduces risk
• Stress management — Chronic stress drives inflammation and accelerates atherosclerosis

Tier 2: Targeted Supplements

• Omega-3 fatty acids — Particularly helpful for patients with elevated triglycerides
• Vitamin D — Low levels are independently associated with increased cardiovascular risk
• CoQ10 — Especially relevant for patients on statins experiencing muscle symptoms
• Berberine — Emerging evidence for metabolic and lipid support

Tier 3: Pharmacologic (When Indicated)

• Statins — First-line for lipid management; CIMT progression can be slowed or reversed with effective treatment
• PCSK9 inhibitors — For familial hypercholesterolemia or statin intolerance
• Aspirin — Low-dose for carefully selected patients based on overall risk assessment

The right combination depends on your specific results, risk profile, and goals. We build a personalized plan around you—not a generic protocol.

---

What Should You Do Next?

1. Don't assume zero CAC means you're in the clear. If you're under 55 with risk factors, or if something feels off, ask about CIMT.

2. Get both tests if you want the complete picture. They're complementary, not competing. Together, they tell the full story.

3. Track your numbers over time. Heart disease is a process, not a single event. Repeat CIMT every 2–3 years to see whether your interventions are working.

4. Make the appointment. If you're ready to go beyond standard care, explore our CIMT screening options and review our pricing.

---

Ready to See the Full Picture?

Standard cardiology often waits until there's obvious disease before acting. We believe you deserve to know what's happening before a heart attack becomes the first symptom.

CIMT gives you that early warning. CAC confirms what you're dealing with when disease is more advanced. Together, they paint the complete picture.

Schedule a CIMT consultation → and find out what your arteries are really telling you. Or review our screening packages and pricing to find the right starting point.

---

References

1. Lester SJ, Eleid MF, Khandheria BK, Hurst RT. "Carotid intima-media thickness and coronary artery calcium score as indications of subclinical atherosclerosis." Mayo Clin Proc. 2009;84(3):229-33. PMID: 19252109 — https://pubmed.ncbi.nlm.nih.gov/19252109/

2. Polak JF, et al. "Carotid Intima-Media Thickness Score, Positive Coronary Artery Calcium Score, and Incident Coronary Heart Disease: The Multi-Ethnic Study of Atherosclerosis." J Am Heart Assoc. 2017;6:e004612. PMID: 28110311 — https://pubmed.ncbi.nlm.nih.gov/28110311/

3. Gronewold J, et al. "Coronary artery calcification, intima-media thickness, and ankle-brachial index are complementary stroke predictors." Stroke. 2014;45(9):2668-74. PMID: 25116876 — https://pubmed.ncbi.nlm.nih.gov/25116876/

4. Nambi V, et al. "Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC study." J Am Coll Cardiol. 2010;55(15):1600-7. PMID: 20378078 — https://pubmed.ncbi.nlm.nih.gov/20378078/

---

Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment recommendations specific to your individual health needs.